| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Oct 22, 2025 | Sale | $0.83 | 32,230 | 26,751 | 29,873 | Oct 24, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Oct 23, 2025 | Sale | $0.82 | 967 | 793 | 28,906 | Oct 24, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jun 24, 2025 | Sale | $4.01 | 3,631 | 14,560 | 62,100 | Jun 26, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jun 03, 2025 | Sale | $3.74 | 2,850 | 10,659 | 65,731 | Jun 04, 2025, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jan 06, 2025 | Sale | $7.63 | 1,706 | 13,017 | 68,581 | Jan 07, 2025, 08:12 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jun 26, 2024 | Sale | $4.75 | 4,163 | 19,774 | 60,187 | Jun 27, 2024, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | May 31, 2024 | Sale | $6.09 | 1,786 | 10,877 | 64,350 | Jun 03, 2024, 08:00 PM | |
| KALA | KALA BIO, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jan 04, 2024 | Sale | $6.74 | 1,227 | 8,270 | 66,136 | Jan 05, 2024, 04:04 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jan 04, 2023 | Sale | $28.54 | 60 | 1,712 | 11,883 | Jan 06, 2023, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Oct 26, 2022 | Sale | $6.51 | 194 | 1,263 | 2,418 | Oct 28, 2022, 04:15 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jun 27, 2022 | Sale | $0.37 | 2,613 | 967 | 130,595 | Jun 29, 2022, 08:12 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jan 04, 2022 | Sale | $1.30 | 2,850 | 3,705 | 133,208 | Jan 05, 2022, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Oct 26, 2021 | Sale | $1.80 | 9,449 | 17,008 | 136,058 | Oct 28, 2021, 08:04 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | CHIEF FINANCIAL OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,452 | 14,148 | 145,507 | Jun 29, 2021, 05:26 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Mary Reumuth | Chief Financial Officer | Jun 09, 2020 | Option/RSU Exercise | $2.64 | 43,477 | 114,771 | 48,293 | Jun 11, 2020, 04:58 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More